Skip to main content
SpringerLink
Log in

Antibacterials

Drug resistance and lack of efficacy

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Amadesi S, et al. Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment. International Journal of Antimicrobial Agents 63: No. 4, Jan 2024. Available from: URL: https://dx.doi.org/10.1016/j.ijantimicag.2024.107107

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antibacterials. Reactions Weekly 2002, 48 (2024). https://doi.org/10.1007/s40278-024-55425-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-55425-1

Search

Navigation